|
Congress has two weeks to finalize FY26 appropriations, including the package that funds CDC, NIH, and the federal health innovation ecosystem. The big picture: Final funding levels aren't set. The Senate's earlier bill had modest increases for prevention, maternal health, and research infrastructure, but those are still being negotiated. What's happening: HHS just whipsawed the field twice in one month. Cancelled $2 billion in mental health and substance use grants with zero warning Reversed the cuts 24 hours later after bipartisan blowback Reinstated all recently laid-off National Institute for Occupational Safety and Health (NIOSH) staff
Why it matters: Recent reversals show advocacy works and technical expertise still has defenders. But the volatility makes planning nearly impossible for organizations mid-grant cycle. What to watch: Full-year funding vs. stopgap: Determines timing for new grants and pilots NIH forward funding language: Needed for multi-year awards that startups and research teams rely on HHS guidance: May re-release paused funding opportunities CDC priorities: Budget language will reveal which areas get near-term innovation investments
The bottom line: The funding environment is unstable, but the infrastructure that supports health innovation continues drawing bipartisan attention as the January 30 deadline approaches.
|
